A new venture capital fund for biotech – dubbed Curie.bio – has launched with what it claims is a whole new model for financing the sector.
The key ingredient will be an approach that allows the founders of start-up companies to get access to seed investment dollars alongside the experience of Curie.bio “co-pilots”, who will help them with a scientific plan, budgeting, timelines, selection of contract partners and recruitment, even before an investment cheque is written.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,